GLP-1 Guides / Policy & Regulation

Policy & Regulation

FDA decisions, coverage rules, and regulatory changes that affect GLP-1 access.

Is Your Compounding Pharmacy Actually at Risk? 503A vs 503B Explained for GLP-1 PatientsThe FDA's 503B proposal alarmed GLP-1 patients — but most are through 503A pharmacies, which are a different category entirely. Here's what it actually means.May 26, 2026 · 5 min read